Scheinberg DA - Search Results

1

Modeling and dosimetry of monoclonal antibody M195 (anti-CD33) in acute myelogenous leukemia.

Sgouros G, Graham MC, Divgi CR, Larson SM, Scheinberg DA. Sgouros G, et al. Among authors: scheinberg da. J Nucl Med. 1993 Mar;34(3):422-30. J Nucl Med. 1993. PMID: 8441034 Free article.

2

Treatment with high dose mouse monoclonal (anti-GD3) antibody R24 in patients with metastatic melanoma.

Bajorin DF, Chapman PB, Wong GY, Cody BV, Cordon-Cardo C, Dantes L, Templeton MA, Scheinberg D, Oettgen HF, Houghton AN. Bajorin DF, et al. Melanoma Res. 1992 Dec;2(5-6):355-62. doi: 10.1097/00008390-199212000-00009. Melanoma Res. 1992. PMID: 1292783

3

Engineered humanized dimeric forms of IgG are more effective antibodies.

Caron PC, Laird W, Co MS, Avdalovic NM, Queen C, Scheinberg DA. Caron PC, et al. Among authors: scheinberg da. J Exp Med. 1992 Oct 1;176(4):1191-5. doi: 10.1084/jem.176.4.1191. J Exp Med. 1992. PMID: 1402660 Free PMC article.

4

Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodies.

Caron PC, Co MS, Bull MK, Avdalovic NM, Queen C, Scheinberg DA. Caron PC, et al. Among authors: scheinberg da. Cancer Res. 1992 Dec 15;52(24):6761-7. Cancer Res. 1992. PMID: 1458463

5

Current applications of monoclonal antibodies for the therapy of hematopoietic cancers.

Scheinberg DA. Scheinberg DA. Curr Opin Immunol. 1991 Oct;3(5):679-84. doi: 10.1016/0952-7915(91)90096-j. Curr Opin Immunol. 1991. PMID: 1661602 Review.

6

A monoclonal antibody for terminal beta-galactose. Use in analysis of glycosphingolipids.

Kalisiak A, Oosterwijk E, Minniti JG, Old LJ, Scheinberg DA. Kalisiak A, et al. Among authors: scheinberg da. Glycoconj J. 1991 Feb;8(1):55-62. doi: 10.1007/BF00731643. Glycoconj J. 1991. PMID: 1726670

7

A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide.

Scheinberg DA, Lovett D, Divgi CR, Graham MC, Berman E, Pentlow K, Feirt N, Finn RD, Clarkson BD, Gee TS, et al. Scheinberg DA, et al. J Clin Oncol. 1991 Mar;9(3):478-90. doi: 10.1200/JCO.1991.9.3.478. J Clin Oncol. 1991. PMID: 1999719 Clinical Trial.

8

Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.

Lemoli RM, Gasparetto C, Scheinberg DA, Moore MA, Clarkson BD, Gulati SC. Lemoli RM, et al. Among authors: scheinberg da. Blood. 1991 Apr 15;77(8):1829-36. Blood. 1991. PMID: 2015406 Free article. Clinical Trial.

9

A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression.

Scheinberg DA, Straus DJ, Yeh SD, Divgi C, Garin-Chesa P, Graham M, Pentlow K, Coit D, Oettgen HF, Old LJ. Scheinberg DA, et al. J Clin Oncol. 1990 May;8(5):792-803. doi: 10.1200/JCO.1990.8.5.792. J Clin Oncol. 1990. PMID: 2332769

10

Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195.

Tanimoto M, Scheinberg DA, Cordon-Cardo C, Huie D, Clarkson BD, Old LJ. Tanimoto M, et al. Among authors: scheinberg da. Leukemia. 1989 May;3(5):339-48. Leukemia. 1989. PMID: 2716349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters